Trial Details
TERMINATEDBasic Information
| Clinical ID | c719 |
|---|---|
| Identifier | NCT03201445 |
| Trial Title | Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | DRUG: Filgotinib|DRUG: Placebo|DRUG: Standard of Care |
Participant Information
| Sponsor | Galapagos NV |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | MALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-07-11 |
|---|---|
| Primary Completion Date | 2020-11-20 |
| Completion Date | 2023-10-24 |